Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
MetLife
MET
|
+$797M |
| 4 |
Chevron
CVX
|
+$491M |
| 5 |
Applied Materials
AMAT
|
+$471M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$937M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$706M |
| 3 |
Gilead Sciences
GILD
|
+$618M |
| 4 |
IBM
IBM
|
+$567M |
| 5 |
AstraZeneca
AZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.15% |
| 2 | Financials | 14.08% |
| 3 | Technology | 12.63% |
| 4 | Energy | 11.41% |
| 5 | Industrials | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCVA
1676
DELISTED
FIRST CAPITAL BANCORP (VA)
FCVA
| $1.94M | ﹤0.01% |
430,021
| – | – |
|
1677
Norwood Financial Corp
NWFL
$368M
| $1.93M | ﹤0.01% |
101,643
-11,426
| -10% | -$219K |
|
1678
Diana Shipping
DSX
$301M
| $1.93M | ﹤0.01% |
+253,332
| New | +$2.02M |
|
|
CART
1679
DELISTED
Carolina Trust BancShares
CART
| $1.93M | ﹤0.01% |
385,312
| – | – |
|
1680
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.9M | ﹤0.01% |
30,477
| – | – |
|
1681
Frequency Electronics
FEIM
$816M
| $1.87M | ﹤0.01% |
+151,800
| New | +$1.66M |
|
1682
Emergent Biosolutions
EBS
$248M
| $1.87M | ﹤0.01% |
83,188
-119,100
| -59% | -$2.77M |
|
1683
La-Z-Boy
LZB
$1.69B
| $1.86M | ﹤0.01% |
80,268
-97,816
| -55% | -$2.42M |
|
|
QTWW
1684
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
| $1.83M | ﹤0.01% |
+316,901
| New | +$1.8M |
|
|
NAK
1685
Northern Dynasty Minerals
NAK
$958M
| $1.83M | ﹤0.01% |
2,188,201
+43,800
| +2% | +$34.5K |
|
|
TBRG
1686
DELISTED
TruBridge
TBRG
| $1.81M | ﹤0.01% |
28,421
-5,800
| -17% | -$366K |
|
|
ARAV
1687
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.76M | ﹤0.01% |
+10,475
| New | +$1.81M |
|
|
ENSV
1688
DELISTED
Enservco Corp.
ENSV
| $1.75M | ﹤0.01% |
45,336
+5,375
| +13% | +$202K |
|
1689
Digimarc Corp
DMRC
$178M
| $1.75M | ﹤0.01% |
53,688
+6,988
| +15% | +$228K |
|
1690
Cal-Maine
CALM
$3.99B
| $1.75M | ﹤0.01% |
47,078
+30,160
| +178% | +$990K |
|
|
SWY
1691
DELISTED
SAFEWAY INC
SWY
| $1.75M | ﹤0.01% |
50,861
-4,607
| -8% | -$157K |
|
1692
Huntington Bancshares
HBAN
$35.5B
| $1.74M | ﹤0.01% |
182,700
-40,216
| -18% | -$378K |
|
|
BKYF
1693
DELISTED
BK KY FINL CORP
BKYF
| $1.72M | ﹤0.01% |
49,416
| – | – |
|
1694
MKS Inc
MKSI
$20.6B
| $1.71M | ﹤0.01% |
+54,731
| New | +$1.59M |
|
|
LKM
1695
DELISTED
Link Motion Inc.
LKM
| $1.7M | ﹤0.01% |
277,087
-42,840
| -13% | -$449K |
|
|
SPNC
1696
DELISTED
Spectranetics Corp
SPNC
| $1.68M | ﹤0.01% |
73,300
| – | – |
|
1697
HCI Group
HCI
$2.41B
| $1.66M | ﹤0.01% |
41,000
+6,746
| +20% | +$261K |
|
|
AXAS
1698
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.65M | ﹤0.01% |
13,217
+2,140
| +19% | +$218K |
|
|
ZGNX
1699
DELISTED
Zogenix, Inc.
ZGNX
| $1.65M | ﹤0.01% |
102,500
+67,662
| +194% | +$1.22M |
|
1700
Thermo Fisher Scientific
TMO
$220B
| $1.63M | ﹤0.01% |
13,812
+3,483
| +34% | +$410K |
|
Similar funds
Wellington Management Group's Q2 2014 Portfolio in Review
As of Q2 2014, Wellington Management Group held 2,343 positions worth $372B, up 3.2% from $360B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2014 filing shows 204 new, 793 increased, 921 reduced and 197 closed positions. Its largest new stake was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M. The largest sale was Teva Pharmaceuticals, an estimated $937M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2014 buy was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M.
- Wellington Management Group added most to Bristol-Myers Squibb in Q2 2014, an estimated $1.52B increase.
- Wellington Management Group's biggest Q2 2014 reduction was Teva Pharmaceuticals, cutting an estimated $937M.
- Wellington Management Group fully exited lululemon athletica in Q2 2014, selling an estimated $456M.
- Wellington Management Group's ten largest holdings make up 15% of its $372B portfolio in Q2 2014.
- Wellington Management Group opened 204 new positions and closed 197 in Q2 2014.
- Wellington Management Group's portfolio value rose 3.2% quarter-over-quarter to $372B.
Based on Wellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.